These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37356807)

  • 1. Preserved Ratio Impaired Spirometry and Risks of Macrovascular, Microvascular Complications and Mortality Among Individuals With Type 2 Diabetes.
    Li G; Jankowich MD; Wu L; Lu Y; Shao L; Lu X; Fan Y; Pan CW; Wu Y; Ke C
    Chest; 2023 Nov; 164(5):1268-1280. PubMed ID: 37356807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preserved Ratio Impaired Spirometry in Relationship to Cardiovascular Outcomes: A Large Prospective Cohort Study.
    Zheng J; Zhou R; Zhang Y; Su K; Chen H; Li F; Hukportie DN; Niu F; Yiu KH; Wu X
    Chest; 2023 Mar; 163(3):610-623. PubMed ID: 36372304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort study.
    Yen FS; Wei JC; Shih YH; Hsu CC; Hwu CM
    Cardiovasc Diabetol; 2023 May; 22(1):109. PubMed ID: 37161539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preserved Ratio Impaired Spirometry, Metabolomics, and the Risk of Type 2 Diabetes.
    Li G; Jankowich MD; Lu Y; Wu L; Shao L; Ke C
    J Clin Endocrinol Metab; 2023 Aug; 108(9):e769-e778. PubMed ID: 36897159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults.
    Wan ES; Balte P; Schwartz JE; Bhatt SP; Cassano PA; Couper D; Daviglus ML; Dransfield MT; Gharib SA; Jacobs DR; Kalhan R; London SJ; Navas-Acien A; O'Connor GT; Sanders JL; Smith BM; White W; Yende S; Oelsner EC
    JAMA; 2021 Dec; 326(22):2287-2298. PubMed ID: 34905031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis.
    Higbee DH; Granell R; Davey Smith G; Dodd JW
    Lancet Respir Med; 2022 Feb; 10(2):149-157. PubMed ID: 34739861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Risks of Mortality and Longitudinal Transition Trajectories in New Potential Subtypes of the Preserved Ratio Impaired Spirometry: Evidence From the English Longitudinal Study of Aging.
    He D; Sun Y; Gao M; Wu Q; Cheng Z; Li J; Zhou Y; Ying K; Zhu Y
    Front Med (Lausanne); 2021; 8():755855. PubMed ID: 34859011
    [No Abstract]   [Full Text] [Related]  

  • 8. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study.
    Wijnant SRA; De Roos E; Kavousi M; Stricker BH; Terzikhan N; Lahousse L; Brusselle GG
    Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 31601717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between preserved ratio impaired spirometry and mortality in the myocardial infarction survivors: a population-based cohort study.
    Li D; Ruan Z; Xie S; Xuan S; Zhao H; Wu B
    BMC Cardiovasc Disord; 2023 Jun; 23(1):331. PubMed ID: 37386454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvascular disease and cardiovascular outcomes among individuals with type 2 diabetes.
    Kaze AD; Santhanam P; Erqou S; Bertoni AG; Ahima RS; Echouffo-Tcheugui JB
    Diabetes Res Clin Pract; 2021 Jun; 176():108859. PubMed ID: 33989668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank.
    Zhang X; Zhao S; Huang Y; Ma M; Li B; Li C; Zhu X; Xu X; Chen H; Zhang Y; Zhou C; Zheng Z
    J Am Heart Assoc; 2024 Jun; 13(11):e032626. PubMed ID: 38818935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Walking pace and microvascular complications among individuals with type 2 diabetes: A cohort study from the UK Biobank.
    Zhu X; Zhang X; Zhou C; Li B; Huang Y; Li C; Gu C; Ma M; Zhao S; Fan Y; Xu X; Chang J; Chen H; Zheng Z
    Scand J Med Sci Sports; 2024 Jan; 34(1):e14501. PubMed ID: 37740713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular health metrics defined by Life's Essential 8 scores and subsequent macrovascular and microvascular complications in individuals with type 2 diabetes: A prospective cohort study.
    Huang ZG; Gao JW; Zhang HF; You S; Xiong ZC; Wu YB; Guo DC; Wang JF; Chen YX; Zhang SL; Liu PM
    Diabetes Obes Metab; 2024 Jul; 26(7):2673-2683. PubMed ID: 38558498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial stiffness and microvascular disease in type 2 diabetes.
    Antonopoulos AS; Siasos G; Oikonomou E; Gouliopoulos N; Konsola T; Tsigkou V; Moschos M; Tentolouris N; Kassi E; Paschou SA; Thanopoulou A; Vavuranakis M; Stone P; Antoniades C; Tousoulis D
    Eur J Clin Invest; 2021 Feb; 51(2):e13380. PubMed ID: 33368197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors, Morbidity, and Mortality in Association With Preserved Ratio Impaired Spirometry and Restrictive Spirometric Pattern: Clinical Relevance of Preserved Ratio Impaired Spirometry and Restrictive Spirometric Pattern.
    Cestelli L; Johannessen A; Gulsvik A; Stavem K; Nielsen R
    Chest; 2024 Aug; ():. PubMed ID: 39209063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
    Polemiti E; Baudry J; Kuxhaus O; Jäger S; Bergmann MM; Weikert C; Schulze MB
    Diabetologia; 2021 Apr; 64(4):814-825. PubMed ID: 33452586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between macrovascular and renal microvascular dysfunction in type 2 diabetes and non-diabetes: the HELIUS study.
    Hayfron-Benjamin CF; Amoah AGB; Maitland-van der Zee AH; Moll van Charante EP; Galenkamp H; van den Born BJ; Agyemang C
    Microvasc Res; 2021 Jul; 136():104162. PubMed ID: 33705823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular and macrovascular complications in type 2 diabetes Ghanaian residents in Ghana and Europe: The RODAM study.
    Hayfron-Benjamin C; van den Born BJ; Maitland-van der Zee AH; Amoah AGB; Meeks KAC; Klipstein-Grobusch K; Bahendeka S; Spranger J; Danquah I; Mockenhaupt F; Beune E; Smeeth L; Agyemang C
    J Diabetes Complications; 2019 Aug; 33(8):572-578. PubMed ID: 31167710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of Mortality and Airflow Limitation in Japanese Individuals with Preserved Ratio Impaired Spirometry.
    Washio Y; Sakata S; Fukuyama S; Honda T; Kan-O K; Shibata M; Hata J; Inoue H; Kitazono T; Matsumoto K; Ninomiya T
    Am J Respir Crit Care Med; 2022 Sep; 206(5):563-572. PubMed ID: 35549659
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial.
    Welsh P; Rankin N; Li Q; Mark PB; Würtz P; Ala-Korpela M; Marre M; Poulter N; Hamet P; Chalmers J; Woodward M; Sattar N
    Diabetologia; 2018 Jul; 61(7):1581-1591. PubMed ID: 29728717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.